Yale, Moderna, and NVIDIA Harness Quantum Computing for Drug Discovery
Yale, Moderna, and NVIDIA explore quantum machine learning to enhance drug discovery. The collaboration focuses on GPU-accelerated simulation of quantum algorithms for predicting molecular properties.
Montai Therapeutics Leverages NVIDIA NIM for Multimodal AI Drug Discovery
Montai Therapeutics collaborates with NVIDIA to develop a multimodal AI platform for drug discovery using NVIDIA NIM microservices.
NVIDIA's NIM Agent Blueprint Transforms Drug Discovery with AI-Driven Virtual Screening
NVIDIA's NIM Agent Blueprint leverages generative AI for faster, cost-effective drug discovery, enhancing hit-to-lead transitions.
Recursion CEO Chris Gibson Discusses AI's Role in Revolutionizing Biopharma
Recursion's CEO Chris Gibson explains how AI and machine learning are accelerating drug discovery and development in the biopharmaceutical industry.
AI-Driven Molecular De-Extinction: A New Frontier in Combating Drug-Resistant Pathogens
Researchers are using AI to resurrect DNA from extinct species to combat drug-resistant pathogens, potentially revolutionizing antibiotic discovery.
Quantum Mechanics Bolsters Drug Discovery with QUELO-G and CUDA Graphs
Quantum mechanics is enhancing drug discovery through the use of QUELO-G and CUDA graphs.